Weekly Roundup for JANUARY 20, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications
Two studies - one using neuropsychological assessments, another examining performance on standardized testing - show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes.
Weekly Roundup for JANUARY 13, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward – ObGynNews
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants with Ob.Gyn News on August 16,
Weekly Roundup for JANUARY 6, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
No Link Between Prenatal Exposure to Antidepressants and Risk for ADHD in Offspring
Consistent with other studies, including a large meta-analysis, this study indicates no increased risk of ADHD in offspring following prenatal exposure to antidepressants.
